Arcus Biosciences, Inc. (RCUS) Stock Price

RCUSStock

$31.57+186.04%52W

Market Cap$3.97B

P/E—

PEG Ratio—

Div yield—

Beta0.93

RCUS Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)43.77%

Price vs S&P 500 (4W)8.30%

VGM Score45.28

Book Value / Share (Quarterly)$3.65

P/TBV (Annual)1.60x

Revenue Growth (3Y)30.16%

Cash Flow / Share (Quarterly)$-3.74

Price vs S&P 500 (YTD)14.44%

Net Profit Margin (TTM)-393.16%

EPS (TTM)$-3.90

10-Day Avg Trading Volume1.26M

EPS Excl Extra (TTM)$-3.90

Revenue Growth (5Y)26.09%

EPS (Annual)$-3.29

ROI (Annual)-48.36%

Net Profit Margin (5Y Avg)-147.92%

Cash / Share (Quarterly)$5.53

Revenue Growth QoQ (YoY)-74.38%

ROA (Last FY)-30.99%

Revenue Growth TTM (YoY)-50.00%

EBITD / Share (TTM)$-4.00

ROE (5Y Avg)-43.02%

Operating Margin (TTM)-415.38%

Cash Flow / Share (Annual)$-3.86

P/B Ratio7.99x

P/B Ratio (Quarterly)8.36x

Net Income / Employee (Annual)$-587,400

EV / Revenue (TTM)31.27x

ROA (TTM)-45.61%

EV / EBITDA (TTM)44.95x

EPS Incl Extra (Annual)$-3.29

Current Ratio (Annual)4.36x

Quick Ratio (Quarterly)3.75x

3-Month Avg Trading Volume1.28M

52-Week Price Return186.04%

Revenue / Employee (TTM)$194,700

Tangible BV / Share (Quarterly)$6.95

P/S Ratio (Annual)15.01x

Asset Turnover (Annual)0.22x

52-Week High$31.73

Operating Margin (5Y Avg)-162.13%

EPS Excl Extra (Annual)$-3.29

CapEx CAGR (5Y)-8.39%

Tangible BV CAGR (5Y)33.69%

26-Week Price Return55.02%

Quick Ratio (Annual)4.32x

13-Week Price Return26.18%

Total Debt / Equity (Annual)0.16x

Current Ratio (Quarterly)3.82x

Enterprise Value$3.66B

Revenue / Share Growth (5Y)10.21%

Asset Turnover (TTM)0.12x

Book Value / Share Growth (5Y)-8.18%

Revenue / Employee (Annual)$411,000

Pretax Margin (Annual)-142.91%

Cash / Share (Annual)$7.83

3-Month Return Std Dev52.20%

Net Income / Employee (TTM)$-765,400

ROE (Last FY)-55.94%

EPS Basic Excl Extra (Annual)$-3.29

P/FCF (TTM)148.32x

Receivables Turnover (TTM)3.84x

Total Debt / Equity (Quarterly)0.22x

EPS Incl Extra (TTM)$-3.90

Receivables Turnover (Annual)12.05x

ROI (TTM)-75.01%

P/S Ratio (TTM)31.69x

Pretax Margin (5Y Avg)-146.54%

Revenue / Share (Annual)$2.30

Tangible BV / Share (Annual)$9.01

Price vs S&P 500 (52W)167.73%

Year-to-Date Return26.40%

5-Day Price Return2.07%

EPS Normalized (Annual)$-3.29

ROA (5Y Avg)-20.03%

Net Profit Margin (Annual)-142.91%

Month-to-Date Return6.85%

Cash Flow / Share (TTM)$-3.91

EBITD / Share (Annual)$-3.50

Operating Margin (Annual)-156.28%

LT Debt / Equity (Annual)0.16x

ROI (5Y Avg)-40.46%

LT Debt / Equity (Quarterly)0.22x

EPS Basic Excl Extra (TTM)$-3.90

P/TBV (Quarterly)2.02x

P/B Ratio (Annual)4.67x

Pretax Margin (TTM)-393.16%

Book Value / Share (Annual)$5.04

Price vs S&P 500 (13W)23.39%

Beta0.93x

P/FCF (Annual)8.58x

Revenue / Share (TTM)$0.93

ROE (TTM)-89.54%

52-Week Low$10.07

vGradeD

gGradeD

mGradeA

vgmGradeC

RCUS Earnings Surprise History

Q2 250.00est. -1.17

Q3 25-1.27est. -1.29

Q4 25-0.89est. -1.07

Q1 26-1.02est. -0.83

Q2 26-0.72est. -0.81

RCUS Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.06

4.05

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
RCUSArcus Biosciences, Inc.	D	D	A	$31.57
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80

About Arcus Biosciences, Inc.

Arcus Biosciences is a late clinical-stage biopharmaceutical company developing differentiated molecular therapies for cancer and inflammatory and autoimmune diseases. The company's pipeline includes several investigational drug candidates designed to address unmet medical needs in these therapeutic areas.